Microglia dysfunction, neurovascular inflammation and focal neuropathologies are linked to IL-1- and IL-6-related systemic inflammation in COVID-19
Fekete R, Simats A, Bíró E, et al. Microglia dysfunction, neurovascular inflammation and focal neuropathologies are linked to IL-1- and IL-6-related systemic inflammation in COVID-19. Nat Neurosci. 2025;28(3):558-576. doi:10.1038/s41593-025-01871-z.
Impaired microglia function and vascular inflammation in COVID
-
Observational study evaluating Long COVID patients treated with H1/H2 antihistamines.
-
Reports improvement in fatigue, cognitive symptoms, tachycardia, and other systemic complaints.
-
Supports the hypothesis that mast cell activation contributes to Long COVID symptom persistence.
-
Suggests immune dysregulation—rather than viral persistence—may drive ongoing symptoms in a subset of patients.